ArticleJournal of experimental & clinical cancer research : CR2019

Ivermectin reverses the drug resistance in cancer cells through EGFR/ERK/Akt/NF-κB pathway.

Lu Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.